Candel Therapeutics, Inc.

Q3 2021 13F Holders

Symbol
CADL
CUSIP
137404109
Type
Equity
Class
COM
Num filings
13
Total reported value, excl. options
$52.9 M
Manager Report Date Value ($000) Shares Option Type